Hainan Free Trade Port to Simplify Drug Import Procedures
The “Provisions on Facilitation of Drug Import in Hainan Free Trade Port,” released in September...
Vaccine
Sinovac’s Varicella Vaccine Receives WHO Pre-Qualification
China-based Sinovac has announced receiving pre-qualification (PQ) status from the World Health Organization (WHO) for...
Walvax Biotech Launches Phase IIIb Trial for mRNA COVID-19 Vaccine
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has announced the initiation of a Phase IIIb...
Recbio’s Neoadjuvant HPV Vaccine Accepted for Review by NMPA
China-based vaccine maker Jiangsu Recbio Technology Co., Ltd (HKG: 2179) announced that a clinical trial...
Shanghai Launches Inhaled COVID-19 Vaccine Booster Program
On October 25, Shanghai began accepting patient reservations for the inhalable recombinant COVID-19 vaccine (adenovirus...
Rongsheng Bio Set for IPO on STAR Board to Boost Vaccine R&D
Shanghai Rongsheng Biotech Co., Ltd is preparing to conduct an initial public offering (IPO) of...
Livzon Launches National Rollout of COVID-19 Vaccine V-01 in China
China-based Livzon Pharmaceutical Group (HKG: 1513) has announced the national promotion of its recombinant novel...
Sinovac Partners with Colombia University to Boost Vaccine R&D
China’s Sinovac (NASDAQ: SVA) has announced a partnership with Universidad de Antioquia of Colombia (UdeA)...
AIM Vaccine Receives CDE Approval for Serum-Free Rabies Vaccine Trial
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving clinical trial approval from the...
Sinopharm’s Wuhan Institute Isolates Monkeypox Strains, Begins Vaccine Research
China’s Wuhan Institute of Biological Products, a research affiliate of Sinopharm’s China National Biotech Group...
Abogen Biosciences Receives UAE Clinical Trial Approval for Omicron BA.4/5 mRNA Vaccine
China’s Abogen Biosciences Co., Ltd, a developer of messenger ribonucleic acid (mRNA) drugs, has announced...
Sinocelltech’s COVID-19 Vaccines SCTV01C and SCTV01E Show Promising Phase III Results
China-based Sinocelltech Group Ltd (SHA: 688520) has announced the preliminary interim analysis results of a...
CDE Releases Draft Guidelines for Tumor Therapeutic Vaccine Clinical Trials
The Center for Drug Evaluation (CDE) has released the “Tumor Therapeutic Vaccines Clinical Trial Technical...
Suzhou Novoprotein Lists on Shanghai’s STAR Market for R&D Expansion
Suzhou Novoprotein Scientific Co., Ltd, a China-based provider of protein technology and application solutions, has...
Moderna’s CMO Expresses Eagerness to Bring mRNA Vaccines to China
The Chief Medical Officer (CMO) of US-based Moderna Inc. (NASDAQ: MRNA), Paul Burton, has been...
AIM Vaccine Plans IPO to Fund Vaccine R&D and Pipeline Expansion
China-based AIM Vaccine Co., Ltd plans to make an initial public offering (IPO) of 9.71...
Immuno Cure BioTech Acquires Majority Stake in Shanghai Teresa Healthcare
Hong Kong-based Immuno Cure BioTech has announced the acquisition of a controlling 92.6% stake in...
Clover Biopharmaceuticals Reports Positive Phase III Data for COVID-19 Vaccine SCB-2019
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has announced additional positive Phase III clinical trial data...
Zhong’ao Biopharmaceutical Secures Series A Funding for Cancer and HPV-Related Disease R&D
China-based Zhong’ao Biopharmaceutical Technology (Guangdong) Co., Ltd. has reportedly raised an undisclosed amount of money...
Luye Life Sciences Partners with Uzbekistan to Establish Vaccine Center
China-based Luye Life Sciences Group has struck a partnership with the Ministry of Innovation and...